Structure-activity relationship study of Pseudellone C as anti-glioma agents by targeting TNF/TNFR signaling pathway

Xufeng Qin1, Weifeng Xu1, Jiangnan Hu1

  • 1Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.

Insights

Novel marine alkaloid derivatives show potent anti-glioma activity, with one compound demonstrating blood-brain barrier penetration and apoptosis induction. These findings offer new therapeutic avenues for brain cancer treatment.

Area of Science:

  • Marine Natural Products Chemistry
  • Medicinal Chemistry
  • Cancer Biology

Background:

  • Glioma is a highly invasive brain tumor with poor drug resistance and high recurrence rates.
  • Novel therapeutic strategies are crucial for improving glioma treatment outcomes.
  • Pseudellone C, a marine triindole alkaloid, exhibits potential anti-central nervous system (CNS) cancer activity.

Purpose of the Study:

  • To design and synthesize novel Pseudellone C derivatives.
  • To evaluate the antiproliferative activity of these derivatives against human glioma cell lines.
  • To investigate the mechanism of action and structure-activity relationships for optimized drug design.

Main Methods:

  • Synthesis of 42 Pseudellone C derivatives.
  • Antiproliferative activity assessment using the CCK-8 assay against U-87MG and LN-229 glioma cell lines.
  • Blood-brain barrier permeability evaluation and mechanistic studies including apoptosis induction via caspase 3 and TNF/TNFR pathway analysis.

Main Results:

  • Ten derivatives displayed significant antiproliferative activity (IC50 < 10 μmol), with potencies 18-39 times greater than Pseudellone C.
  • Derivative 4o showed promising blood-brain barrier permeability.
  • Derivative 4o induces apoptosis through the TNF/TNFR pathway, activating caspase 3.

Conclusions:

  • Novel Pseudellone C derivatives possess potent anti-glioma activity.
  • Derivative 4o is a promising candidate for further development due to its efficacy, BBB penetration, and apoptotic mechanism.
  • Structure-activity relationship analysis provides a basis for rational drug design against glioma.